Medicare Part B will continue to pay hospitals for 340B drugs at the rate of average sales price (ASP) plus [...] …
Category: Regulatory
Medicare issued a final rule today to implement a $9 billion lump sum payment to 340B hospitals and to cut [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Forty-four health systems and hospitals sued federal healthcare agencies over their recent decision to end a 340B COVID-related registration flexibility [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The recent end of a 340B program waiver for hospitals is wrong, hurts hospitals and their patients, and is bound [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Health Resources and Services Administration (HRSA) confirmed today it is ending a 340B program waiver issued early in the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Indian biopharmaceutical manufacturer Biocon Biologics has notified 340B covered entities about a new national drug code (NDC) for insulin glargine-yfgn, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Regulators are seeking input on a contractor to help it shield drug manufacturers from giving duplicate 340B discounts and new [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Witnesses recently told a U.S. House subcommittee that Congress should cut Medicare payments for 340B drugs. The House Energy and [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A final rule to implement the 340B administrative dispute resolution (ADR) process arrived this week at the last stage of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A total of 16 covered entities (CEs) owe repayment to drugmakers, five more than reported a month ago, according to [...] …